PuraStat as secondary therapy for hemostasis in Mallory−Weiss syndrome with oral antithrombotic medication
2024

Using PuraStat for Bleeding in Mallory-Weiss Syndrome

publication Evidence: low

Author Information

Author(s): Higashino Makoto, Murakami Hidehiro, Hirata Tetsu, Miyaoka Hiroaki

Primary Institution: Saiseikai Matsuyama Hospital

Hypothesis

Can PuraStat effectively achieve hemostasis in patients with Mallory-Weiss syndrome who are on antithrombotic medication?

Conclusion

PuraStat can achieve complete hemostasis in Mallory-Weiss syndrome when traditional methods fail.

Supporting Evidence

  • PuraStat has been used effectively for non-variceal gastrointestinal bleeding.
  • The patient had multiple lacerations diagnosed as Mallory-Weiss syndrome.
  • Initial treatment with clips did not stop the bleeding, but PuraStat did.
  • The patient was discharged without further deterioration after treatment.

Takeaway

If someone is bleeding in their stomach because of vomiting, a special gel called PuraStat can help stop the bleeding when other methods don't work.

Methodology

The patient was treated with endoscopy and PuraStat was applied to the bleeding site after initial clipping failed.

Limitations

This is a single case report, and further studies are needed to confirm the efficacy of PuraStat in a larger population.

Participant Demographics

The patient was a 67-year-old man with a history of coronary artery bypass grafting and was taking clopidogrel.

Digital Object Identifier (DOI)

10.1002/deo2.70033

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication